Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03141892 · ClinicalTrials.gov registry record
FreeStyle Libre Flash Glucose Monitoring System Accuracy Study
A clinical trial, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- 50
- Enrollment target
NCT03141892: Completed study, sponsored by Abbott Diabetes Care.
NCT03141892 is a clinical trial that has completed, run by Abbott Diabetes Care. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03141892 has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This is a pivotal, non-randomized, single arm, multi-center, prospective, non-significant risk study to evaluate the FreeStyle Libre Flash Glucose Monitoring System.
Primary Outcome
System performance will be characterized with respect to YSI reference venous plasma sample measurements.
Interventions
- DEVICE FreeStyle Libre Flash Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-04-13 |
| Est. Completion | 2017-05-30 |
What the finished NCT03141892 record still lists
NCT03141892 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which FreeStyle Libre Flash Glucose Monitoring System is the first listed.
NCT03141892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03141892 about?
NCT03141892 is a clinical study titled "FreeStyle Libre Flash Glucose Monitoring System Accuracy Study". This is a pivotal, non-randomized, single arm, multi-center, prospective, non-significant risk study to evaluate the FreeStyle Libre Flash Glucose Monitoring System.
What is the current status of trial NCT03141892?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2017-04-13. Estimated completion is 2017-05-30.
What interventions are being tested in trial NCT03141892?
The interventions under investigation include: FreeStyle Libre Flash Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT03141892?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI